This message was sent to ##Email##
Some employers have told staff to work from home amid the coronavirus outbreak, which the World Health Organization has now declared a pandemic.
But nurses and other medical professionals can't.
| || ANA MASSACHUSETTS NEWS & UPDATES|
Dear ANA Massachusetts Members,
Nurses play an essential role in leading the delivery of care and advancing the health of their communities. As the professional association representing all nurses in the Commonwealth, ANAMASS takes pride in advocating for patients and the profession, engaging members from the bedside to the boardroom, and finding innovative solutions. Healthcare is consistently at the forefront of concern for the public and for nurses. ANAMASS must be decisive, assured and transparent in communication of these efforts. Policy, legislation, lobbying and legislation are all vital efforts to positively impact the optics of nursing and recognition of nurses as leaders in healthcare. ANA’s ability to advocate and collaborate with bipartisan leaders contributed to Congress’ passage of $8.3 billion emergency spending for COVID-19. Details of the spending package can be found here.
We recognize that in light of the latest COVID-19 developments, the emerging and fluid staffing needs of many nursing employers – both acute care and long-term care, and potential need to redistributed stockpiles of medical supplies to ensure caregiver safety across the commonwealth, nurses are concerned. We are too. COVID-19 is placing demands on a public health system which we know already has weak areas in the access of and care for the vulnerable and the underserved. Nurses are on the front lines every day; we have a professional responsibility to keep up to date with the latest information from the Centers for Disease Control and the World Health Organization.
Please review Information for Healthcare Workers, which can be found at https://www.cdc.gov/coronavirus/2019-ncov/hcp/index.html, as well as Information for Healthcare Facilities, which can be found at https://www.cdc.gov/coronavirus/2019-ncov/healthcare-facilities/guidance-hcf.html. The World Health Organization also provides information for both Healthcare Providers and the general public at https://www.who.int/news-room/q-a-detail/q-a-coronaviruses.
At the national level, ANA has expressed concerns that the CDC’s interim guidelines released 3/10/20, which included updated recommendations advising that facemasks for clinical providers (including nurses at the bedside) are an acceptable alternative when there is a shortage of N95 respirators, were based solely on supply chain and manufacturing challenges rather than scientific evidence supporting transmission mode and disease prevention. ANA has called on the CDC to investigate and communicate on the transmission mode for coronavirus so that decisions about appropriate PPE are based on the best information available, as well as to identify metrics for when the interim guidance will be rescinded to ensure that clinical providers and health care facilities can prepare to continue caring for their patients and communities. For more information, visit https://www.nursingworld.org/news/news-releases/2020/ana-responds-to-coronavirus-pandemic-declaration/.
We recognize that it is extremely important that we have a ready supply of personal protective equipment to ensure the safety of the patient, but also the safety of healthcare providers as well as the public. As many public health organizations, officials, and others have indicated, one of the consequences of the widespread panic over COVID-19 has been misinformation and the general public’s purchase and use of medical supplies in a manner inconsistent with their intended purpose. The National Institute for Occupational Safety and Health (NIOSH) has provided the following Recommended Guidance for Extended Use and Limited Reuse of N95 Filtering Facepiece Respirators in Healthcare Settings: https://www.cdc.gov/niosh/topics/hcwcontrols/recommendedguidanceextuse.html
ANA and ANA Massachusetts together will continue to lead the efforts to advocate for the best interest of all nurses and the broader healthcare community.
March 25, 2020
Healthcare Reform Efforts:
Applying a Health Equity and Social Justice Lens
Live Program Cancelled - stay tuned for alternative educational programming.
Friday, May 8
Royal Sonesta Hotel
The new co-editors of the ANA Massachusetts Newsletter, Barbara Belanger and Inge Corless, invite your comments, suggestions, critiques, information, and articles. This is YOUR Newsletter and we want it to be interesting, informative and useful to you. Don’t hesitate to get in touch with us at firstname.lastname@example.org. The deadline to submit for the June edition is April 10.
We are looking to interview nurses working on the coronavirus outbreak in direct care, public health policy, research, or other related roles. Please contact: Gail B. Gall, PhD, RN at email@example.com.
The 2019 novel coronavirus (2019-nCoV) is a new strain of coronavirus, first detected in Wuhan, China. It has not been previously known to spread in humans. Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases. Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV) are examples of coronaviruses. For more information, click here.
April 16, 2020
1 – 2:30 pm ET
Did you know that nurses at all levels of practice are substantially more likely to be investigated and disciplined by the nursing board than they are to be sued for professional malpractice?
And licensure discipline is more consequential than lawsuits because it effects a professional's ability to continue practicing.
This webinar is being presented by Edie Brous, JD, MS, MPH, RN.
Last Spring, over 23,000 RNs pre-registered for the ANA membership webinar for Nursing Leaders, "Managing the Legal Risks of Nursing Practice" led by Edie Brous. As you may have heard – these nurses were not disappointed! 91% of nurses surveyed gave the webinar at least a 9 on a 10 point scale!
Space is limited! Attendance is FREE.
Individual and Group* pre-registration is required.
You don't have to attend the live webinar! Register now to receive 24/7 access to the recording.
Register by February 5, 2020, to receive a gift, the ANA e-book, "Moral Distress and You."
As an ANA member, you can participate in our Navigate Nursing webinar series for FREE. That's a $75 value, and you'll get 1 free contact hour each time you participate!
Plus, ANA is now offering you an easy way to sign up for all 4 webinars at one time – the 2020 Navigate Nursing Webinar Bundle.
Click here for more information.
Did you know?
Studies show that workplace violence affects care quality and outcomes, contributes to the development of psychological conditions, and reduces nurses’ job satisfaction and commitment. ANA has developed strategies to address this under-reported epidemic and strengthen zero-tolerance policies.
- One in four nurses is assaulted on the job
- Only 20%-60% of those incidents are reported
- 13% of missed workdays are due to workplace violence
Download the FREE #EndNurseAbuse Resource Guide now to help you recognize, respond to, and follow up on violence in the workplace. Get educated and make a commitment to report all abuse you encounter.
The World Health Organization's (WHO) State of the World's Nursing Report will launch on World Health Day, April 7, 2020. The report aims to provide evidence to make a stronger case for governments to invest in nursing.
To learn more about the report and see how you can contribute to its development and launch, join the State of the World's Nursing Report webinar on Sept. 10 at 8:00 GMT or 14:00 GMT (find time conversions here). Speakers from WHO, the International Council of Nurses, Nursing Now, and Jhpiego will present during the one-hour webinar. Participants are encouraged to ask questions during the webinar and in advance via email to firstname.lastname@example.org.
Register for the 8:00 GMT webinar here.
Register for the 14:00 GMT webinar here.
UMass GSN Continuing Education Programs allows nurses to take courses to further their professional and/or academic goals. Courses are available on campus and online to best fit our student’s schedules. Register today and take advantage of a curriculum combining clinical expertise, contemporary research, and world class faculty!
| || NURSING & HEALTHCARE NEWS|
Infection Control Today
Infection preventionists might be called upon to assess the condition of healthcare workers who may have been exposed to COVID-19, according to Connie Steed, MSN, RN, CIC, FAPIC, the president of the Association for Professionals in Infection Control and Epidemiology. Steed told Infection Control Today® that the IPs would be functioning under the Interim U.S. Guidance for Risk Assessment and Public Health Management of Healthcare Personnel with Potential Exposure in a Healthcare Setting to Patients with Coronavirus Disease. The guidance was modified on March 7 by the U.S. Centers for Disease Control and Prevention as part of its response to COVID-19.
We may be one step closer to a universal flu vaccine, according to a new study.
In the study, published March 9 in the journal Annals of Internal Medicine, researchers found that a single dose of the vaccine, called Flu-v, elicited greater immune responses than placebo in a small trial involving 175 volunteers. These results suggest that the vaccine is safe and potentially effective, and the research will usher Flu-v into the final stages of clinical testing.
Cancer death rates declined between 2001 and 2017 in the United States for all cancer sites combined, according to the Annual Report to the Nation on the Status of Cancer, published in Cancer.
Rates declined among all major racial and ethnic groups, as well as among men, women, adolescents, young adults and children.
The report also showed overall cancer incidence rates leveled off among men and increased slightly for women between 2012 and 2016.
“The United States continues to make significant progress in cancer prevention, early detection and treatment,” Robert R. Redfield, MD, director of the CDC, said in a press release. “[Although] we are encouraged that overall cancer death rates have decreased, there is still much more we can do to prevent new cancers and support communities, families and cancer survivors in this ongoing battle.”
By Dorothy L. Tengler
A new study on COVID-19, led by researchers at Johns Hopkins Bloomberg School of Public Health, estimates 5.1 days for incubation period and suggests that about 97.5 percent of people who develop symptoms of infection will do so within 11.5 days of exposure. The researchers estimated that for every 10,000 individuals quarantined for 14 days, only about 101 would develop symptoms after being released from quarantine. These estimates imply that in 101 out of every 10,000 cases, people will develop symptoms after 14 days of active monitoring or quarantine.
Becker's Hospital Review
Seven nurses talked about how they handle bullying behavior in a recent survey from Becker's Hospital Review. "A culture of support and empowerment is key to an effective nursing team. As nursing leaders, it is important to empower our nurse managers to recognize bullying and address it — even if it may be uncomfortable," said Trish Celano, RN.
Medical News Today
In 2007, Timothy Ray Brown became the first person ever whom doctors declared to be cured of HIV. At the time, they referred to him publicly as the Berlin patient.
His journey toward a cure was not straightforward. After having received an HIV diagnosis in the 1990s, Mr. Brown received antiretroviral treatment — the usual course of action for an HIV infection.
However, later on, he also received a diagnosis of acute myeloid leukemia, for which he eventually required a stem cell transplant.
As he was looking for a suitable donor match, his doctor had the idea to try an experiment. He looked for a donor with a specific genetic mutation that made them practically immune to HIV.
Receiving stem cells from this donor, it turned out, not only treated Mr. Brown’s leukemia but also cured the HIV infection.
Now, as a study featuring in The Lancet shows, another person has officially been cured of HIV, also thanks to a stem cell transplant.
Royal College of Surgeons in Ireland via Medical Xpress
A chemical found in some vaping products can produce a highly toxic gas when heated up, according to new research from RCSI University of Medicine and Health Sciences.
Led by researchers at RCSI's Department of Chemistry, the study is published in the current edition of PNAS.
By Scott E. Rupp
As the pandemic that is the novel coronavirus grows, telehealth technology is finding its footing as people become more concerned about their level of exposure to the virus and as health systems expect to be overwhelmed with treating those affected. President Donald Trump recently signed an $8.3 billion package that, in part, allows Department of Health and Human Services Secretary Alex Azar to waive Medicare telehealth payment restrictions during the coronavirus emergency.
American Assocaition for the Advancement of Science via EurekAlert!
Joana Neves is the 2019 grand prize winner of the Sartorius & Science Prize for Regenerative Medicine & Cell Therapy, for work that offers a promising approach to improve the outcome of regenerative stem cell-based therapies aimed at delaying age-related degenerative diseases.
Using the fruit fly Drosophila as a model organism, Neves discovered an evolutionarily conserved mechanism of tissue repair — immune modulation by the protein MANF — which she harnessed to restore visual function in old, blind mice with retinal disease.
University of Sheffield via ScienceDaily
A new "toolkit" to repair damaged DNA that can lead to aging, cancer and Motor Neurone Disease has been discovered by scientists at the Universities of Sheffield and Oxford.
Published in Nature Communications, the research shows that a protein called TEX264, together with other enzymes, is able to recognize and "eat" toxic proteins that can stick to DNA and cause it to become damaged. An accumulation of broken, damaged DNA can cause cellular aging, cancer and neurological diseases such as MND.
Johns Hopkins University via Medical Xpress
More than 35 million Americans take statin drugs daily to lower their blood cholesterol levels. Now, in experiments with human cells in the laboratory, researchers at Johns Hopkins Medicine have added to growing evidence that the ubiquitous drug may kill cancer cells and have uncovered clues to how they do it.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063